US8740602052
US8740602052
Takeda Pharmaceutical Company L
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 59.83B EUR | 25.33B EUR | 29.26B EUR | 24.63B EUR |
Enterprise Value | 5.14T EUR | 4.5T EUR | 4.32T EUR | 4.22T EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | 0.11x |
Forward P/E | 35.34x | -- | -- | -- |
Price to Sales | 0.01x | 0.01x | 0.01x | 0.01x |
Price to Book | 1.24x | 0x | 0x | 0x |
EV/Revenue | 1.11x | 0.98x | 0.96x | 1.24x |
EV/EBITDA | 4.11x | 6.98x | 6.19x | 3.66x |
Price to FCF (P/FCF) | 0.11x | 0.05x | 0.06x | 0.05x |
EV/FCF | 9.48x | 9.26x | 8.87x | 8.86x |
FCF Yield | 904.9% | 1,920.66% | 1,663.21% | 1,934.94% |